Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (48)

41

Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis : systematic review and metaanalysis of randomized controlled trials

enthalten in: The Journal of rheumatology | 2008

von Saad, A. | Symmons, D. | Noyce, P. | +1

CommentIn: Nat Clin Pract Rheumatol. 2008 Oct;4(10):510-1. - PMID 18695713

42

Tumor necrosis factor alpha drugs in rheumatoid arthritis : systematic review and metaanalysis of efficacy and safety

enthalten in: BMC musculoskeletal disorders | 2008

von Alonso-Ruiz, A. | Pijoan, J. | Ansuategui, E. | +3

43

Rituximab in patients with rheumatoid arthritis : systematic review

enthalten in: Orvosi hetilap | 2007

von Brodszky, V. | Czirják, L. | Géher, P. | +6

44

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis : a systematic review and economic evaluation

enthalten in: Health technology assessment (Winchester, England) | 2007

von McLeod, C. | Bagust, A. | Boland, A. | +7

45

Dose escalation of the anti-TNF-alpha agents in patients with rheumatoid arthritis. A systematic review

enthalten in: Rheumatology (Oxford, England) | 2007

von Ariza-Ariza, R. | Navarro-Sarabia, F. | Hernández-Cruz, B. | +3

46

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness

enthalten in: Health technology assessment (Winchester, England) | 2006

von Chen, Y. | Jobanputra, P. | Barton, P. | +5

47

Etanercept and efalizumab for the treatment of psoriasis : a systematic review

enthalten in: Health technology assessment (Winchester, England) | 2006

von Woolacott, N. | Hawkins, N. | Mason, A. | +8

48

Biologic therapies for psoriasis. A systematic review

enthalten in: The Journal of rheumatology | 2006

von Boehncke, W. | Prinz, J. | Gottlieb, A.